GlassScriptPhysician profile
Ricardo D Ribeiro
NPI 1386993194
$1,206.66
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.03 · 2020: $48.27 · 2021: $134 · 2022: $395 · 2023: $516 · 2024: $24.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $361.93 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $168.64 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.26 | 2021-2023 | Stiolto Respimat |
| Amgen INC. | $83.56 | 2022-2023 | Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $79.62 | 2021-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $68.82 | 2023 | Farxiga |
| Hologic Sales and Service, LLC | $57.33 | 2019 | |
| Exact Sciences Corporation | $48.12 | 2023 | Cologuard Collection Kit |
| Seqirus USA INC | $42.14 | 2022-2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Lilly USA, LLC | $40.09 | 2022-2023 | Mounjaro |
| E.R. Squibb & Sons, L.L.C. | $28.58 | 2023 | Eliquis |
| Abbott Laboratories | $24.73 | 2024 | Freestyle Libre 3 |
| Medtronic, INC. | $22.51 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.92 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $18.51 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $15.40 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $15.29 | 2021 | |
| Abbvie INC. | $13.13 | 2023 | |
| Dynavax Technologies Corporation | $6.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricardo Ribeiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.